Mapping the EORTC QLQ C-30 onto the EQ-5D instrument: The potential to estimate QALYs without generic preference data

Value in Health

Volumn 12, Issue 1, 2009, Pages 167-171

  McKenzie, Lynda ^a   Van Der Pol, Marjon ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Quality adjusted life years; Quality of life; Regression modeling; Utility assessment

Indexed keywords

ARTICLE; CANCER PAIN; CONTROLLED STUDY; EUROPEAN UNION; HEALTH CARE ORGANIZATION; HEALTH CARE SYSTEM; HUMAN; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE;

AGED; COST-BENEFIT ANALYSIS; FEMALE; GREAT BRITAIN; HEALTH STATUS; HUMANS; MALE; NEOPLASMS; PALLIATIVE CARE; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; REGRESSION ANALYSIS;

EID: 58849136327     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1111/j.1524-4733.2008.00405.x     Document Type: Article

References (17)

1. National Institute for Clinical Excellence. Guide to the methods of technology appraisal. Available from: http://www.nice.org.uk/niceMedia/pdf/TAP- Methods.pdf [Accessed November 2, 2007].
2. Dolan P. Output measures and valuation in health. In: Drumond M, McGuire A, eds. Economics Evaluation in Health Care. New York: Oxford University Press, 2001.
3. Dolan P. Modelling valuation for EuroQol health states. Med Care 1997 35 : 351 63.
4. Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ 2002 21 : 271 92.
5. Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. Med Care 1989 27 : S217 32.
6. Brazier JE, Kolotkin RL, Crosby RD, Williams GR. Estimating a preference-based single index for the Impact of Weight on Quality of Life (IWQOL-Lite) Instrument from the SF-6D. Value Health 2004 7 : 490 8.
7. Tsuchiya A, Brazier JE, McColl E, Parkin D. Deriving preference-based single indices from non-preference based condition-specific instruments: converting AQLQ into EQ5D indices. Sheffield Health Economics Group Discussion Paper Series 02/1, University of Sheffield, 2002.
8. Brennan DS, Spencer AJ. Mapping oral health related quality of life to generic health state values. BMC Health Serv Res 2006 6 : 96 106.
9. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ C-30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993 85 : 365 76.
10. Bottomley A, Aaronson NK. International perspective on health-related quality-of-life research in cancer clinical trials: the European Organisation for Research and Treatment of Cancer experience. J Clin Oncol 2007 25 : 5082 6.
11. EuroQol© Group. EQ-5D User Guide. Rotterdam : EuroQol Group, 2000.
12. Brooks R. EuroQol: the current state of play. Health Policy 1996 3 : 53 72.
13. Brazier J, Deverill M, Green C, et al. A review of the use of health status measures in economic evaluation. Health Technol Assess 1999 3 : 9.
14. Shenfine J, McNamee P, Steen N, et al. A pragmatic randomised controlled trial of the cost-effectiveness of palliative therapies for patients with oesophageal cancer. Health Technol Assess 2005 9 : 5.
15. Veall MR, Zimmermann KF. Pseudo-R2 measures for some common limited. Dependent variable models. J Econ Surv 1996 10 : 241 59.
16. Prescott RJ, Kunkler IH, King CC, et al. PRIME: a randomised controlled trial of post-operative radiotherapy following breast conserving surgery in a minimum risk older population. Health Technol Assess 2007 11 : 31.
17. Marra CA, Woolcott JC, Kopec JA, et al. A comparison of generic, indirect utility measures (the HU12, HU13, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Soc Sci Med 2005 60 : 1571 782.